Latest filing published 07 Jul 2021 for Cell Source, Inc., €12k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Benzion Abraham Friedman on record concern Cell Source, Inc. Between 4 December 2017 and 30 June 2021, the trades on record add up to 8 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 7 July 2021 with a transaction (€12k) in Cell Source, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations